High throughput screening of ultrafiltration and diafiltration processing of monoclonal antibodies via the ambr® crossflow system
Sign Up to like & getrecommendations! Published in 2019 at "Biotechnology Progress"
DOI: 10.1002/btpr.2929
Abstract: As the biopharmaceutical industry moves toward high concentration of monoclonal antibody drug substance, additional development is required early on when material is still limited. A key constraint is the availability of predictive high‐throughput low‐volume filtration… read more here.
Keywords: system; crossflow system; ambr crossflow; ultrafiltration diafiltration ... See more keywords